NUCLEAR RECEPTOR BINDING SET DOMAIN PROTEINS: ORCHESTRATING ANTI-TUMOR IMMUNITY AND THE PROMISE OF TARGETED DEGRADATION THERAPIES. Eur. J. Emerg. Mol. Sci. 2024, 1 (01), 69-79.